277 related articles for article (PubMed ID: 17827966)
1. Cost-minimization analysis comparing topiramate with standard treatments in migraine prophylaxis.
Ergun H; Gulmez SE; Tulunay FC
Eur Neurol; 2007; 58(4):215-7. PubMed ID: 17827966
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of topiramate in migraine prevention: results from a pharmacoeconomic model of topiramate treatment.
Brown JS; Papadopoulos G; Neumann PJ; Friedman M; Miller JD; Menzin J
Headache; 2005 Sep; 45(8):1012-22. PubMed ID: 16109115
[TBL] [Abstract][Full Text] [Related]
3. Cost effectiveness of topiramate in the prevention of migraines in the United States: an update.
Brown JS; Rupnow MF; Neumann P; Friedman M; Menzin J
Manag Care Interface; 2006 Dec; 19(12):31-8. PubMed ID: 17274479
[TBL] [Abstract][Full Text] [Related]
4. Topiramate: new indication. Migraine prevention: best avoided.
Prescrire Int; 2006 Aug; 15(84):132-3. PubMed ID: 16989025
[TBL] [Abstract][Full Text] [Related]
5. Two center, randomized pilot study of migraine prophylaxis comparing paradigms using pre-emptive frovatriptan or daily topiramate: research and clinical implications.
Cady RK; Voirin J; Farmer K; Browning R; Beach ME; Tarrasch J
Headache; 2012 May; 52(5):749-64. PubMed ID: 22188311
[TBL] [Abstract][Full Text] [Related]
6. Topiramate in migraine prophylaxis: long-term impact on resource utilization and cost.
Silberstein SD; Feliu AL; Rupnow MF; Blount AC; Boccuzzi SJ
Headache; 2007 Apr; 47(4):500-10. PubMed ID: 17445099
[TBL] [Abstract][Full Text] [Related]
7. Topiramate in migraine prevention: evidence-based medicine from clinical trials.
Silberstein SD
Neurol Sci; 2004 Oct; 25 Suppl 3():S244-5. PubMed ID: 15549548
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of migraine prevention: the case of topiramate in the UK.
Brown JS; Papadopoulos G; Neumann PJ; Price M; Friedman M; Menzin J
Cephalalgia; 2006 Dec; 26(12):1473-82. PubMed ID: 17116098
[TBL] [Abstract][Full Text] [Related]
9. Topiramate for migraine prophylaxis.
Drug Ther Bull; 2006 Aug; 44(8):62-4. PubMed ID: 16903488
[TBL] [Abstract][Full Text] [Related]
10. Topiramate 100 mg/day in migraine prevention: a pooled analysis of double-blind randomised controlled trials.
Bussone G; Diener HC; Pfeil J; Schwalen S
Int J Clin Pract; 2005 Aug; 59(8):961-8. PubMed ID: 16033621
[TBL] [Abstract][Full Text] [Related]
11. Topiramate for migraine prevention in adolescents: a pooled analysis of efficacy and safety.
Winner P; Gendolla A; Stayer C; Wang S; Yuen E; Battisti WP; Nye JS
Headache; 2006; 46(10):1503-10. PubMed ID: 17115983
[TBL] [Abstract][Full Text] [Related]
12. Topiramate in migraine prophylaxis: data from a pooled analysis and open-label extension study.
Bussone G; Usai S; D'Amico D
Neurol Sci; 2006 May; 27 Suppl 2():S159-63. PubMed ID: 16688622
[TBL] [Abstract][Full Text] [Related]
13. Topiramate for migraine prevention.
Wenzel RG; Schwarz K; Padiyara RS
Pharmacotherapy; 2006 Mar; 26(3):375-87. PubMed ID: 16503717
[TBL] [Abstract][Full Text] [Related]
14. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
Dodick DW; Freitag F; Banks J; Saper J; Xiang J; Rupnow M; Biondi D; Greenberg SJ; Hulihan J;
Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844
[TBL] [Abstract][Full Text] [Related]
15. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial.
Winner P; Pearlman EM; Linder SL; Jordan DM; Fisher AC; Hulihan J;
Headache; 2005; 45(10):1304-12. PubMed ID: 16324162
[TBL] [Abstract][Full Text] [Related]
16. Rizatriptan for treatment of acute migraine in patients taking topiramate for migraine prophylaxis.
Seeburger JL; Cady RK; Winner P; MacGregor A; Valade D; Ge Y; Zhang Y; Hustad CM; Strickler N; Schaefer E; Connor KM; Ho TW
Headache; 2012 Jan; 52(1):57-67. PubMed ID: 22078129
[TBL] [Abstract][Full Text] [Related]
17. Topiramate in the prophylactic treatment of migraine in children.
Campistol J; Campos J; Casas C; Herranz JL
J Child Neurol; 2005 Mar; 20(3):251-3. PubMed ID: 15832623
[TBL] [Abstract][Full Text] [Related]
18. A randomized, one-year clinical trial comparing the efficacy of topiramate, flunarizine, and a combination of flunarizine and topiramate in migraine prophylaxis.
Luo N; Di W; Zhang A; Wang Y; Ding M; Qi W; Zhu Y; Massing MW; Fang Y
Pain Med; 2012 Jan; 13(1):80-6. PubMed ID: 22233396
[TBL] [Abstract][Full Text] [Related]
19. Topiramate in Migraine Prevention: A 2016 Perspective.
Silberstein SD
Headache; 2017 Jan; 57(1):165-178. PubMed ID: 27902848
[TBL] [Abstract][Full Text] [Related]
20. The effect of migraine prophylaxis on migraine-related resource use and productivity.
Láinez MJ
CNS Drugs; 2009 Sep; 23(9):727-38. PubMed ID: 19689164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
